Inventor
BEATCH GREGORY N
CA26 patents
⚠️ This page may combine multiple inventors who share the name “BEATCH GREGORY N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CARDIOME PHARMA CORP
17 patentsUS7053087B1May 30, 2006
Aminocycloalkyl cinnamide compounds for arrhythmia and analgesics and anesthetics
CARDIOME PHARMA CORP72 citations97
US7259184B2Aug 21, 2007
Ion channel modulating compounds and uses thereof
CARDIOME PHARMA CORP47 citations95
US7345087B2Mar 18, 2008
Aminocyclohexyl ether compounds and uses thereof
CARDIOME PHARMA CORP32 citations92
US7345086B2Mar 18, 2008
Uses of ion channel modulating compounds
CARDIOME PHARMA CORP17 citations92
US7057053B2Jun 6, 2006
Ion channel modulating compounds and uses thereof
CARDIOME PHARMA CORP40 citations92
US6979685B1Dec 27, 2005
Cycloalkyl amine compounds and uses thereof
CARDIOME PHARMA CORP32 citations92
US7534790B2May 19, 2009
Ion channel modulating compounds and uses thereof
CARDIOME PHARMA CORP15 citations91
US7524879B2Apr 28, 2009
Ion channel modulating compounds and uses thereof
CARDIOME PHARMA CORP17 citations91
US7101877B2Sep 5, 2006
Ion channel modulating compounds and uses thereof
CARDIOME PHARMA CORP32 citations91
US7674820B2Mar 9, 2010
Ion channel modulating activity I
CARDIOME PHARMA CORP23 citations88
US7875611B2Jan 25, 2011
Ion channel modulating compounds and uses thereof
CARDIOME PHARMA CORP8 citations83
US7507545B2Mar 24, 2009
Ion channel modulating activity method
CARDIOME PHARMA CORP12 citations82
US8008342B2Aug 30, 2011
Ion channel modulating compounds and uses thereof
CARDIOME PHARMA CORP5 citations72
US7820712B2Oct 26, 2010
Uses of ion channel modulating compounds
CARDIOME PHARMA CORP2 citations63
US7105534B2Sep 12, 2006
Imidazo[1,2-α]pyridine ether compounds as ion channel modulators
CARDIOME PHARMA CORP7 citations61
US6388095B1May 14, 2002
Indole-containing quaternary ammonium compounds
CARDIOME PHARMA CORP3 citations60
US7687536B2Mar 30, 2010
Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics
CARDIOME PHARMA CORP0 citations51
XENON PHARMACEUTICALS INC
4 patentsUS11135214B2Oct 5, 2021
Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener
XENON PHARMACEUTICALS INC3 citations73
US11091441B2Aug 17, 2021
Solid state crystalline forms of a selective potassium channel modulator
XENON PHARMACEUTICALS INC4 citations69
US12319657B1Jun 3, 2025
Solid state crystalline forms of a selective potassium channel modulator
XENON PHARMACEUTICALS INC0 citations59
US12178811B2Dec 31, 2024
Methods of treating depressive disorders
XENON PHARMACEUTICALS INC0 citations53